Loading clinical trials...
Loading clinical trials...
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Conditions
Interventions
KRN23
Locations
6
United States
University of California San Francisco
San Francisco, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Clinical Research Center, Indiana University School of Medicine
Indianapolis, Indiana, United States
Duke Clinical Research Unit
Durham, North Carolina, United States
University of Texas Health Science Center at Houston
Houston, Texas, United States
Shriners Hospital for Children - Canada
Montreal, Quebec, Canada
Start Date
February 1, 2012
Primary Completion Date
September 1, 2013
Completion Date
June 1, 2014
Last Updated
June 18, 2024
NCT03745521
NCT03775187
NCT04188964
NCT04842032
NCT02537431
NCT06067932
Lead Sponsor
Kyowa Kirin Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions